May 12, 2016Open Access

Initiating Sacubitril/Valsartan (LCZ696) in Heart Failure: Results of TITRATION, a Double-Blind, Randomized Comparison of Two Uptitration Regimens

Structured PICO

Does a 3-week versus 6-week uptitration regimen of sacubitril/valsartan improve tolerability and target dose attainment in patients with heart failure?

Population

Patients with heart failure

Intervention

Sacubitril/valsartan uptitration from 50 to 200 mg twice daily over 3 weeks

Comparator

Sacubitril/valsartan uptitration from 50 to 200 mg twice daily over 6 weeks

Outcome

Tolerability profile and attainment of target dosesafety

A more gradual 6-week uptitration of sacubitril/valsartan maximizes target dose attainment in heart failure patients previously on low-dose ACEI/ARB.

Abstract

Initiation/uptitration of sacubitril/valsartan from 50 to 200 mg twice daily over 3 or 6 weeks had a tolerability profile in line with other HF treatments. More gradual initiation/uptitration maximized attainment of target dose in the low-dose ACEI/ARB group.

Demander à l'IA

Bookmark

View Full Paper

Cite This Study

Senni et al. (Thu,) studied this question.

synapsesocial.com/papers/69eff994bce9831ba4f73789 https://doi.org/https://doi.org/10.1002/ejhf.548

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Demander à l'IA

Bookmark

View Full Paper